"Lab Chat: A new use for immunotherapy?" - Andrew Joseph
A new study catalogs the vast array of immune cells surrounding early-stage lung cancers - discovering that even nascent tumors evoke immune changes. By mapping those responses, scientists may be better able to direct new immunotherapy treatments at early-stage cancers. It also suggests that immunotherapy, typically given to patients with later-stage cancers, could be an effective treatment early on. "We are expanding the patient cohort quite substantially. We are also working on clinical trials where patients with early cancer will receive some immunotherapy to see if by the time of surgery, the tumors are being attacked," said Dr. Miriam Merad of Mount Sinai.
- Miriam Merad, MD, PhD, Professor of Oncological Sciences, Medicine, Hematology and Medical Oncology at The Tisch Cancer Institute at Mount Sinai
Additional Coverage:
Researchers Discover Potential Boost to Immunotherapy
Mar 30, 2020 View All Press Releases